Combined transcatheter aortic valve replacement and left atrial appendage occlusion in patients ineligible for oral anticoagulation: A case series

Freire, Antonio Fernando Diniz; Filippini, F; Bignoto, Tiago Costa; Brito, Pedro Henrique Ferro de; Nicz, Pedro Felipe Gomes; Melo, Pedro Henrique Magalhães Craveiro de; Silva, Ricardo Cavalcante e; Queiroga, Marcelo; Ribeiro, Henrique Barbosa; Procópio, Arthur Guilherme Magalhães; Bezerra, Cristiano Guedes; Grube, Eberhard; Abizaid, Alexandre; Filho, Roberto Kalil; Brito, Fábio Sândoli de

doi:10.1016/j.jccase.2022.04.008

Search citation statements

Order By: Relevance

Paper Sections

Select...

Left Atrial Appendage Occlusion1

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2023

2024

Publication Types

Select...

Article2

Relationship

Self Cite0

Independent2

Authors

Journals

Cited by 2 publications

(1 citation statement)

References 10 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The risk of ischemic stroke or systemic embolism was reduced with concurrent left atrial appendage occlusion (LAAO) performed during the procedure compared to that without LAAO [45]. In a recent case study, simultaneous TAVR and LAAO were found to be a realistic and secure combination for patients with severe AS and AF who were deemed ineligible for OACs [46]. LAAO after TAVR may be an option for long-term oral anticoagulation medication in elderly patients with contraindications to anticoagulation, high bleeding risk, high risk of drug interactions, or the need for dual antiplatelet therapy due to coronary stent implantation.…”

Section: Left Atrial Appendage Occlusionmentioning

confidence: 99%

Transcatheter Aortic Valve Replacement in Elderly Patients: Opportunities and Challenges

Huang,

Yan,

et al. 2023

JCDD

View full text Add to dashboard Cite

Over the past two decades, the rapid evolution of transcatheter aortic valve replacement (TAVR) has revolutionized the management of severe aortic stenosis (AS) in the elderly. The prevalence of comorbidities in elderly AS patients presents a considerable challenge to the effectiveness and prognosis of patients after TAVR. In this article, we aim to summarize some of the clinical aspects of the current use of TAVR in elderly patients and attempt to highlight the challenges and issues that need further consideration.

show abstract

Section: Left Atrial Appendage Occlusionmentioning

confidence: 99%